(Q36162179)

12 August 2017

Mutation screening of RAD51C in high-risk breast and ovarian cancer families (English)

1 reference

12 August 2017

1 reference

5

Fergus J Couch

1 reference

12 August 2017

2

Xianshu Wang

1 reference

12 August 2017

4

Noralane M Lindor

1 reference

12 August 2017

Wenping Lu

1

1 reference

PMC publication ID

3418444

12 August 2017

Hongsheng Lin

series ordinal

3

1 reference

12 August 2017

1 September 2012

1 reference

12 August 2017

1 reference

12 August 2017

11

1 reference

12 August 2017

3

1 reference

12 August 2017

381-385

1 reference

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

RAD51C germline mutations in breast and ovarian cancer cases from high-risk families

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Germline mutations in RAD51D confer susceptibility to ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Mutation screening of RAD51C in male breast cancer patients.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

RAD51C germline mutations in breast and ovarian cancer patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

In silico analysis of missense substitutions using sequence-alignment based methods

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Genetic predisposition to breast cancer: past, present, and future

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Identification and purification of two distinct complexes containing the five RAD51 paralogs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Complex formation by the human RAD51C and XRCC3 recombination repair proteins

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418444

Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9523-9

Mutation of the RAD51C gene in a Fanconi anemia-like disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9523-9

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9523-9

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9523-9

RAD51C is a susceptibility gene for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9523-9

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9523-9

RAD51C germline mutations in Chinese women with familial breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22476429

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22476429

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22476429

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10689-012-9523-9

1 reference

12 August 2017

1 reference

PMC publication ID

3418444

12 August 2017

PubMed publication ID

22476429

1 reference

PMC publication ID

3418444